Your browser doesn't support javascript.
loading
Response and survival predictors in a cohort of 319 patients with Waldenström macroglobulinemia treated with ibrutinib monotherapy.
Castillo, Jorge J; Sarosiek, Shayna R; Gustine, Joshua N; Flynn, Catherine A; Leventoff, Carly R; White, Timothy P; Meid, Kirsten; Guerrera, Maria L; Kofides, Amanda; Liu, Xia; Munshi, Manit; Tsakmaklis, Nicholas; Hunter, Zachary R; Patterson, Christopher J; Branagan, Andrew R; Treon, Steven P.
Afiliação
  • Castillo JJ; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Sarosiek SR; Department of Medicine, Harvard Medical School, Boston, MA.
  • Gustine JN; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Flynn CA; Department of Medicine, Harvard Medical School, Boston, MA.
  • Leventoff CR; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • White TP; Department of Medicine, Boston University School of Medicine, Boston, MA; and.
  • Meid K; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Guerrera ML; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Kofides A; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Liu X; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Munshi M; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Tsakmaklis N; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Hunter ZR; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Patterson CJ; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Branagan AR; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Treon SP; Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
Blood Adv ; 6(3): 1015-1024, 2022 02 08.
Article em En | MEDLINE | ID: mdl-34965304
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Marrocos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Marrocos País de publicação: Estados Unidos